4_M_1440049442.jpg?#)
Cardiff Oncology (NASDAQ:CRDF) Earns Hold Rating from Analysts at Jefferies Financial Group
Jefferies Financial Group initiated coverage on shares of Cardiff Oncology (NASDAQ:CRDF – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports. The firm issued a hold rating and a $3.50 price target on the stock. A number of other analysts have also recently commented on CRDF. William Blair reiterated an “outperform” rating […]
Jefferies Financial Group initiated coverage on shares of Cardiff Oncology (NASDAQ:CRDF – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports. The firm issued a hold rating and a $3.50 price target on the stock. A number of other analysts have also recently commented on CRDF. William Blair reiterated an “outperform” rating […]
